View in EDS HTML Full Text PDF Full Text

The real-world efficacy and safety of frontline therapy of obinutuzumab plus bendamustine for untreated high-tumor-burden follicular lymphoma.

Saved in:
Bibliographic Details
Title: The real-world efficacy and safety of frontline therapy of obinutuzumab plus bendamustine for untreated high-tumor-burden follicular lymphoma.
Authors: Nagata, Hiroaki1 (AUTHOR), Tsukamoto, Taku1 (AUTHOR) ttsuka@koto.kpu-m.ac.jp, Kobayashi, Tsutomu2 (AUTHOR), Takahashi, Ryoichi3 (AUTHOR), Okano, Akira3 (AUTHOR), Uchiyama, Hitoji2 (AUTHOR), Kawata, Eri4,5 (AUTHOR), Uoshima, Nobuhiko5 (AUTHOR), Kaneko, Hiroto6 (AUTHOR), Fuchida, Shin-ichi7 (AUTHOR), Nishiyama, Daichi8 (AUTHOR), Nakao, Mitsushige9 (AUTHOR), Fujino, Takahiro1 (AUTHOR), Mizutani, Shinsuke1 (AUTHOR), Shimura, Yuji1 (AUTHOR), Kuroda, Junya1 (AUTHOR) junkuro@koto.kpu-m.ac.jp
Source: International Journal of Clinical Oncology. Mar2025, Vol. 30 Issue 3, p593-603. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:13419625
DOI:10.1007/s10147-025-02691-8